Lerner Research Institute News & More

Lerner Research Institute is home to basic, translational and clinical research at Cleveland Clinic. With nearly 1,500 researchers and support personnel in 175 laboratories in 10 departments, we are one of the largest research institutes in the nation, consistently ranking in the top 10 in National Institutes of Health funding, a benchmark of research success.

Cleveland Clinic News Room Archive

Polygenic Risk Scoring Helps Identify People at High Risk for Epilepsy

Understanding Genetics of Parkinson’s Disease in Latinos

Predicting Cancer Versus Autism Risk in PTEN Patients

Uncovering How Hemeprotein Maturation, Regulation Contributes to Disease

$2M DoD Grant for Augmented Reality Protocols to Help Troops Return to Duty After Brain Injury

$2.4M NIH Grant to Study Relationship Between Inflammation, Blood-Brain Barrier in MS

Beyond the Gut: The Urinary Tract Microbiome’s Role in Urinary Stone Disease

New Research Published in Cancer Discovery Identifies New Drug Target for Treating Glioblastoma

Genetic Status and Clinical Management of Bilateral Pheochromocytoma

Get to Know the 2019 Class of PRISM Students

Meet the 2019 Class of Molecular Medicine PhD Students

Human Interactome Illuminates Personalized Drug Discovery

NIH Awards $3M Grant to Study Long-Term Risk of Osteoarthritis after Knee Surgery

Gray Foundation Awards $1.6M for Breast Cancer Research

Co-Laboratories Spark New Research Collaboration

$3.5M Grant Awarded to Annotate and Exchange Virtual Anatomy

New Centers of Excellence Announced: Accelerating Bench to Bedside Research

NIH Grant to Study Mechanism of Blood Clotting Factor Secretion Renewed

Using Artificial Intelligence to Deliver Personalized Radiation Therapy

Beyond Blood Production: Novel Role of Iron Discovered

$3M Grant to Test Novel Brain Stimulation Technique in Patients with Post-Stroke Paralysis

New NIH Grant to Study Effects of Exercise on Parkinson’s Progression

New Grant to Target Immunosuppressive Cells in Glioblastoma

Visualizing PTEN: Seeing Mutations Differently

The Potential Regenerative Power of Mesenchymal Stem Cells for Ischemic Kidney Injury

New Causal Gene Implicated in Coronary Artery Disease

Carpal Tunnel Syndrome Intervention Improves Symptoms in Two Weeks

The Microbiome of the Inflamed Aorta: What Can We Discern?

Helmsley Trust Awards $4.3M for Crohn’s Disease Research

New Oxygen-Sensing Molecule Implicated in Cancer Development

The Unexpected Role of Secreted Proteases in Birth Defects

Insights on Glucocorticoid Receptors’ Role in Drug-Resistant Epilepsy

Chronicling How a Cancer Drug Works by Triggering the Immune System

Advancing Therapy by Measuring the ‘Games’ Cancer Cells Play

Defining the Link Between Inflammation and Cancer

New Statistical Guidelines in Urology Research

Major Player in Epilepsy Pathology Uncovered

Sex Differences Loom Large in Glioblastoma Development

NCI-Funded Study Aims to Enhance Glioblastoma Treatment

Using Augmented Reality to Enhance Liver Cancer Therapy

Five Researchers Win Annual Fund Grants

The Search for Causes of Idiopathic Pulmonary Arterial Hypertension

FDA Recognizes PTEN Variant Criteria

Personal Mutanomes Meet Precision Oncology

A New Target for Outsmarting Obesity